Complete Wegovy and Mounjaro Dosing Schedule Analysis
Wegovy and Mounjaro Dose Comparison: UK Stock Availability
The key advantage of comparing Wegovy and Mounjaro dose schedules through EverydayMeds is our Reliable UK stock availability across all dose strengths. Unlike the supply shortages that affected Wegovy availability in 2022-2023, our partnership with Novo Nordisk ensures all five Wegovy doses remain consistently in stock. For your Wegovy and Mounjaro dose comparison, we maintain comprehensive inventory of Wegovy 0.25mg through 2.4mg, plus the recently approved 7.2mg dose becoming available soon.
This reliable stock position means you can start either treatment immediately after prescriber approval, without joining waitlists or experiencing treatment interruptions. Our temperature-controlled supply chain from our GPhC-registered pharmacy (#9012878) ensures both medications arrive in perfect condition. When conducting your wegovy and mounjaro dose comparison, knowing both options are readily available removes the anxiety of potential supply delays that could disrupt your weight management journey.
Wegovy and Mounjaro Dose Comparison: Pricing Structure
Understanding the cost implications of your Wegovy and Mounjaro dose comparison requires examining each treatment's pricing at different stages. Wegovy follows a 5-dose escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). These prices reflect the discount applied using code FIRST40 for new customers or DOSE25 for returning customers at checkout. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides your first three months for £299.99.
For your Wegovy and Mounjaro dose comparison budget planning, consider that both treatments require 12-16 weeks of dose escalation before reaching maintenance levels. Wegovy's maintenance cost stabilises at £209.99 monthly, with our Ultimate Stability Trio (three 2.4mg pens) providing three months of maintenance supply for £649.99. The convenience of bundle ordering ensures uninterrupted treatment whilst reducing delivery frequency, supporting consistent adherence to your prescribed schedule.
Clinical Evidence Supporting Wegovy and Mounjaro Dose Comparison
When examining clinical evidence for your Wegovy and Mounjaro dose comparison, both treatments demonstrated significant efficacy in their respective clinical programmes. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme encompassed over 4,500 participants across multiple studies, establishing Wegovy's evidence base across different patient populations.
For your Wegovy and Mounjaro dose comparison consideration, it's important to note that direct head-to-head trials between these treatments have not been completed, making percentage comparisons inappropriate due to different trial designs and populations. Both medications work through appetite regulation mechanisms, though Mounjaro's dual GIP/GLP-1 approach differs from Wegovy's GLP-1-only mechanism, potentially influencing individual response patterns.
How Wegovy Works in Your Dose Comparison Analysis
Understanding Wegovy's mechanism is crucial for your Wegovy and Mounjaro dose comparison decision-making process. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural glucagon-like peptide-1 hormone. This hormone is released from your intestines after eating and signals feelings of fullness to your brain's appetite centres. By activating these same receptors, Wegovy may help reduce appetite and promote satiety after smaller meals, supporting your weight management efforts when combined with reduced-calorie diet and increased physical activity. The medication may also slow gastric emptying, helping you feel satisfied for longer periods after eating.
Ordering Process for Your Wegovy and Mounjaro Dose Comparison
Accessing either treatment for your Wegovy and Mounjaro dose comparison begins with our streamlined 3-minute online clinical assessment, designed to gather essential medical history and current health status. Our qualified prescribers review your assessment within 3 working days (express 24-hour service available) to determine suitability for your chosen treatment. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled packaging to maintain product integrity. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict quality standards before dispatch, providing peace of mind throughout your treatment journey.
Storage and Practical Considerations in Dose Comparison
Practical storage differences may influence your Wegovy and Mounjaro dose comparison decision, particularly for frequent travellers. Wegovy pens must be stored in the fridge at 2-8°C before first use but can remain at room temperature (below 30°C) for up to 6 weeks once removed, compared to Mounjaro's 21-day room temperature limit. Both treatments use pre-filled pens for once-weekly injection, though Wegovy's FlexTouch pen design may feel different from Mounjaro's KwikPen system. The dose escalation schedule cannot be shortened for either treatment, requiring patient commitment to the prescribed titration timeline over 12-16 weeks before reaching maintenance doses.
UK Supply Chain Reliability for Wegovy and Mounjaro Dose Comparison
A critical factor in your Wegovy and Mounjaro dose comparison is supply chain reliability, particularly given historical availability challenges with GLP-1 medications. EverydayMeds has established direct relationships with Novo Nordisk (Wegovy manufacturer) and Eli Lilly (Mounjaro manufacturer) to ensure consistent stock levels across all dose strengths. Our inventory management system tracks usage patterns and maintains safety stock levels to prevent treatment interruptions during your dose escalation or maintenance phases.
This supply reliability means your Wegovy and Mounjaro dose comparison can focus on clinical suitability rather than availability concerns. Our automated reorder reminders help maintain treatment continuity, whilst our customer service team provides proactive communication about any potential supply issues. This comprehensive approach ensures your chosen treatment remains available throughout your weight management journey, supporting optimal clinical outcomes.
Expert Support for Your Wegovy and Mounjaro Dose Comparison Decision
Making the right choice in your Wegovy and Mounjaro dose comparison requires expert clinical guidance tailored to your individual circumstances. Our qualified prescribers consider factors including your medical history, current medications, lifestyle requirements, and treatment preferences when recommending the most suitable option. Both treatments are prescription-only medicines requiring ongoing monitoring and support throughout the treatment period. Whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-hormone mechanism, our clinical team provides comprehensive support from initial assessment through maintenance therapy. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, using code FIRST40 for new customers or DOSE25 for returning customers at checkout to access our competitive pricing structure.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
